- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04801979
Normative Values and Reference Equations of a New Incremental Step Test for the Assessment of Exercise Capacity for Portuguese Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary aim of this project is to establish normative values and reference equations generated from Portuguese adults without disabilities of a new step test for the assessment of exercise capacity.
The investigators will perform a cross-sectional study in Portuguese adults (over 18 years) without disabilities. The study will be advertised at the university campus, surrounding areas, and interested participants can contact the research team for participation. The participants who agree will be seen by the principal investigator who will explain the nature of the study and assess eligibility for the study. The participants will sign informed consent.
For each participant, the study will be performed in one day. The participants will perform the incremental step test twice (30 minutes apart).
In addition, socio-demographic information (age and sex), anthropometric measures (weight, height, and body mass index), and clinical data (smoking status, comorbidities, and level of physical activity) will be collected.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4200-072
- Rui Vilarinho
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Portuguese nacionality
- Adults without disabilities aged >18 years
- Participants with body mass index between 18 and 30 kg/m2
Exclusion Criteria:
- Acute or chronic conditions (respiratory disease, cardiac disease, signs of cognitive or neuromuscular impairment, and significant musculoskeletal disorder)
- Conditions that could interfere with the ability to perform the step test
- Use of walking aids
- Post-symptomatic COVID-19 infected participants
- High-performance athletes
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of steps
Time Frame: Through test completion, duration of the test 15 minutes
|
The primary outcome will be the amount of steps performed in the step test
|
Through test completion, duration of the test 15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyspnea during the tests
Time Frame: Through test completion, duration of the test 15 minutes
|
Dyspnea experienced during the tests, monitored with the modified Borg scale, that ranges from 0 to 10, where 0 represents no dyspnea and 10 the worst dyspnea.
|
Through test completion, duration of the test 15 minutes
|
|
Fatigue during the tests
Time Frame: Through test completion, duration of the tests 15 minutes
|
Fatigue experienced during the tests, monitored with the modified Borg scale, that ranges from 0 to 10, where 0 represents no fatigue and 10 the worst fatigue
|
Through test completion, duration of the tests 15 minutes
|
|
Heart rate during the tests
Time Frame: Through test completion, duration of the tests 15 minutes
|
Heart rate assessed during the tests, monitored with a cardiofrequencimeter
|
Through test completion, duration of the tests 15 minutes
|
|
Oxygen saturation during the tests
Time Frame: Through test completion, duration of the tests 15 minutes
|
Oxygen saturation assessed during the tests, monitored with a pulse oximeter
|
Through test completion, duration of the tests 15 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- New_Step_Test
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adults Without Disabilities
-
Washington University School of MedicineRecruitingAdapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities (HARP3)Falls | Adults | Fall Prevention | Disabilities PhysicalUnited States
-
Aveiro UniversityCompletedOlder Adults Without Any Specific Clinical ConditionPortugal
-
The Hong Kong Polytechnic UniversityActive, not recruitingOlder Adults Without Any Specific Clinical ConditionHong Kong
-
University of California, San FranciscoNational Institute on Minority Health and Health Disparities (NIMHD); Mission...RecruitingOlder Adults Without Any Specific Clinical Condition | Social Networks | Vaccine Uptake | RSV ImmunizationUnited States
-
Kafkas UniversityEnrolling by invitationOlder Adults Without Any Specific Clinical Condition | Older Adults (65 Years and Older)Turkey (Türkiye)
-
University Medical Centre LjubljanaActive, not recruitingMigraine | Migraine Headache | Migraine Headache, With or Without Aura | Migraine in AdultsSlovenia
-
Universidade da CoruñaCompletedOlder Adults Without Any Specific Clinical Condition | Autonomic Nervous System Imbalance | Transcutaneous Vagus Nerve StimulationSpain
-
Groupe Hospitalier Mutualiste de GrenobleCompletedDisabilities Mental | Disabilities PhysicalFrance
-
Icahn School of Medicine at Mount SinaiResearch Foundation for Mental Hygiene, Inc.; Autism Science Foundation; The...RecruitingAutism Spectrum Disorder | FOXP1 | Mental Retardation With Language Impairment and With or Without Autistic FeaturesUnited States
-
University of South CarolinaNational Institute on Drug Abuse (NIDA)Not yet recruitingYoung Adults | Past-3-month Non-medical Use of Prescription Opioids | Without Substance Use Disorders | Social Media UsersUnited States
Clinical Trials on Incremental Step Test
-
Technical University of MadridCompleted
-
Centre Hospitalier Universitaire de BesanconUnknownVentilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD (CONvEX)Chronic Obstructive Pulmonary Disease SevereFrance
-
Swiss Federal Institute of TechnologyCompleted
-
Queen Margaret UniversityRecruitingMultiple SclerosisUnited Kingdom
-
University Hospital Birmingham NHS Foundation TrustCompleted
-
Centre Hospitalier Metropole SavoieUniversité Savoie Mont Blanc; Laboratoire de Psychologie et NeuroCognition...RecruitingBeta Thalassemia Transfusion DependentFrance
-
Nagihan AcetNot yet recruitingMask Usage Condition
-
Biruni UniversityCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
University of Rennes 2Recruiting